Na tej stronie
01ANIP cena
02Zrzut ekranu
03Wykres
04Podziały akcji
06Wyniki
07Wycena i wskaźniki
13Dywidendy
14Zyski
15Pełne podstawowe wskaźniki
16Sprawozdania
17Właściciele instytucjonalni (13F)
18Aktywiści i właściciele 5%+
19Insiderzy spółki
20Posiadanie ETF-ów
21Konsensus
22Równi
23Wiadomości
26Moje wskaźniki
ANIP ANI Pharmaceuticals, Inc. - Common Stock
NASDAQ · Pharmaceuticals · Wyświetl na SEC EDGAR ↗ zamknij Paź 2, 2026 10-K/10-Q Sie 7, 2026
$72,18
· % zakresu 52 tyg.
· powyżej minimum
· do maksimum
$69,5852tyg. minimum
$97,0052tyg. maksimum
Kapitalizacja Rynkowa (MRQ)
$1.72B
P/E (TTM)
15.7
EPS (TTM)
$4.60
Przychody (TTM)
$978M
Twoje odznaki
Zakres 52 tyg.
$70–$97
Ocena Analityków
BUY
Cena Docelowa
$106
P/E
15.7
ROE
21.0%
Marża Zysku Netto
11.1%
Twój pasek odznak jest pusty — przypnij metrykę w dowolnym miejscu na tej stronie.
ANIP Migawka akcji Cena, kapitalizacja rynkowa, P/E, EPS, ROE, zadłużenie/kapitał własny, zakres 52-tygodniowy
Cena
$72.18
Kapitalizacja Rynkowa (MRQ)
$1.72B
P/E (TTM)
15.7
EPS (TTM)
$4.60
Przychody (TTM)
$978M
Stopa dywidendy
0.07%
ROE (TTM)
21.0%
D/E Dług/Kapitał (MRQ)
0.5
Zakres 52 tyg.
$70–$97
ANIP Wykres ceny akcji Dzienny OHLCV ze wskaźnikami technicznymi — przesuwaj, powiększaj i dostosowuj widok
zakres
kreski
Granularność słupków dostosowuje się do wybranego okresu — najedź kursorem na wykres, aby zobaczyć otwarcia/maksima/minima/zamknięcia dla danego słupka.
Podziały akcji
| Data ex-dywidendy | Podział | Typ |
|---|---|---|
| 18 lipca 2013 | 1-for-6 | Odwrotny |
| 4 czerwca 2012 | 1-for-6 | Odwrotny |
| 3 czerwca 2002 | 1-for-10 | Odwrotny |
Wyniki 10-letnie Trendy przychodów, zysku netto, marż i EPS
Przychody$883M2016-12-31 → 2025-12-31
EPS$3.322016-12-31 → 2025-12-31
Wolny przepływ pieniężny$171M2016-12-31 → 2025-12-31
Marża netto11.1%2016-12-31 → 2025-12-31
Wycena i wskaźniki
Wycena Wskaźniki P/E, P/S, P/B, EV/EBITDA — czy akcje są drogie, czy tanie?
| Wskaźnik | Trend 5-letni | ANIP | średnia z 5 lat | Mediana porównawcza | Werdykt |
|---|---|---|---|---|---|
| P/E (TTM) | 15.7średnia z 5 lat ≈1.8 | ≈1.8 | · | · | |
| P/S (TTM) | 1.8średnia z 5 lat ≈2.4 | ≈2.4 | 15.5 | Niedowartościowany | |
| P/B (MRQ) | 2.9średnia z 5 lat ≈2.7 | ≈2.7 | 4.1 | Niedowartościowany | |
| EV / EBITDA | 15.6średnia z 5 lat ≈496.0 | ≈496.0 | · | · | |
| Cena / FCF (TTM) | 10.0średnia z 5 lat ≈209.2 | ≈209.2 | · | · | |
| Cena / Przepływy pieniężne (TTM) | 9.1średnia z 5 lat ≈49.9 | ≈49.9 | · | · | |
| EV / Revenue (EV / Przychody) | 2.0średnia z 5 lat ≈2.8 | ≈2.8 | · | · | |
| EV / FCF | 10.1średnia z 5 lat ≈257.8 | ≈257.8 | · | · | |
| Cena / Wartość księgowa materialna (MRQ) | 11.7średnia z 5 lat ≈30.7 | ≈30.7 | · | · |
Mediana porównawcza jest obliczana na znormalizowanej podstawie dla każdej metryki i może nie zawsze odpowiadać podstawie TTM/MRQ pokazanej dla tej akcji.
Rentowność Marże brutto, operacyjne i netto; ROE, ROA, ROIC
| Wskaźnik | Trend 5-letni | ANIP | średnia z 5 lat | Mediana porównawcza | Werdykt |
|---|---|---|---|---|---|
| Marża Operacyjna (TTM) | 15.4%średnia z 5 lat ≈-1.4% | ≈-1.4% | -132.8% | Najwyższa półka | |
| EBITDA Margin (Marża EBITDA) | 12.6%średnia z 5 lat ≈2.9% | ≈2.9% | -126.4% | Najwyższa półka | |
| Marża przed opodatkowaniem (TTM) | 14.6%średnia z 5 lat ≈-6.9% | ≈-6.9% | -45.1% | Najwyższa półka | |
| Marża Zysku Netto (TTM) | 11.1%średnia z 5 lat ≈-5.0% | ≈-5.0% | -110.2% | Najwyższa półka | |
| ROA (TTM) | 7.6%średnia z 5 lat ≈-1.4% | ≈-1.4% | -27.5% | Najwyższa półka | |
| ROE (TTM) | 21.0%średnia z 5 lat ≈-2.8% | ≈-2.8% | -26.1% | Najwyższa półka | |
| ROIC | 10.7%średnia z 5 lat ≈1.5% | ≈1.5% | -27.0% | Najwyższa półka |
Zdrowie finansowe Dług, płynność, wypłacalność — siła bilansu
| Wskaźnik | Trend 5-letni | ANIP | średnia z 5 lat | Mediana porównawcza | Werdykt |
|---|---|---|---|---|---|
| Dług / Kapitał Własny (MRQ) | 0.5średnia z 5 lat ≈0.8 | ≈0.8 | 0.3 | Wysokie zadłużenie | |
| Wskaźnik bieżący (MRQ) | 2.9średnia z 5 lat ≈3.2 | ≈3.2 | 11.8 | Niska płynność | |
| Quick Ratio (Wskaźnik Szybkości) | 2.0średnia z 5 lat ≈2.3 | ≈2.3 | 10.2 | Niska płynność | |
| Dług długoterminowy / Kapitał własny (MRQ) | 0.5średnia z 5 lat ≈0.7 | ≈0.7 | · | · |
Rozwój Wzrost przychodów, EPS i zysku netto: r/r, CAGR 3-letni, CAGR 5-letni
| Wskaźnik | Trend 5-letni | ANIP | średnia z 5 lat | Mediana porównawcza | Werdykt |
|---|---|---|---|---|---|
| Revenue YoY (Przychody R/R) | 43.8%średnia z 5 lat ≈34.8% | ≈34.8% | · | · | |
| Revenue CAGR 3Y (Przychody CAGR 3L) | 40.8%średnia z 5 lat ≈38.4% | ≈38.4% | · | · | |
| Revenue CAGR 5Y (Przychody CAGR 5L) | 33.5% | · | · | · |
Efektywność kapitałowa Rotacja aktywów, rotacja zapasów, rotacja należności
| Wskaźnik | Trend 5-letni | ANIP | średnia z 5 lat | Mediana porównawcza | Werdykt |
|---|---|---|---|---|---|
| Asset Turnover (Rotacja aktywów) | 0.6średnia z 5 lat ≈0.5 | ≈0.5 | 0.1 | Najwyższa półka | |
| Receivables Turnover (Rotacja należności) | 3.5średnia z 5 lat ≈2.8 | ≈2.8 | 4.5 | Słaby | |
| Revenue / Employee (Przychody / pracownika) | ≈$910.7K | · | · | · |
wartość · ≈ średnia z 5 lat · mediana branżowa · werdykt względem mediany
Dywidendy Stopa dywidendy, wskaźnik wypłaty, historia dywidend, 5-letni CAGR
Stopa Dywidendy0.07%
Wskaźnik Wypłaty Dywidendy1.5%
Historia zysków EPS faktyczny vs szacowany, zaskoczenie %, wskaźnik trafień, data następnych wyników
Średnie zaskoczenie
22.2%
Następny raport
Lis 05, 2026
| Okres | Raport | EPS Actual | EPS Szacowany | Niespodzianka |
|---|---|---|---|---|
| 30 czerwca 2026 | Sie 12, 2026 | $2.21 | $2.09 | 5.7% |
| 31 marca 2026 | Maj 8, 2026 | $2.05 | $1.33 | 54.0% |
| 31 grudnia 2025 | $2.33 | $2.04 | 14.5% | |
| 30 września 2025 | $2.04 | $1.79 | 14.0% | |
| 30 czerwca 2025 | $1.80 | $1.45 | 24.3% | |
| 31 marca 2025 | $1.70 | $1.41 | 20.6% |
Pełne podstawowe wskaźniki Wszystkie wskaźniki roczne — rachunek zysków i strat, bilans, przepływy pieniężne
Rachunek zysków i strat
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $883M | $614M | $487M | $316M | $216M | $208M | $207M | $202M | $177M | $129M | $76M | $56M | |
| Cost of Revenue | · | · | · | · | · | $87M | $63M | $73M | $79M | $49M | $13M | $11M | |
| R&D Expense | $52M | $45M | $34M | $22M | $11M | $16M | $20M | $15M | $9M | $3M | $3M | $3M | |
| SG&A Expense | $318M | $250M | $162M | $124M | $84M | $65M | $56M | $44M | $32M | $28M | $21M | $18M | |
| Operating Expenses | $772M | $614M | $440M | $352M | $256M | $224M | $190M | $166M | $149M | $109M | $44M | $36M | |
| Operating Income | $111M | $584.0K | $47M | $-35M | $-40M | $-16M | $16M | $35M | $28M | $20M | $33M | $20M | |
| Interest Income | $13M | $16M | $9M | $461.0K | · | · | · | · | · | · | · | · | |
| Other Non-op | $2M | $-4M | $-159.0K | $670.0K | $-4M | $-494.0K | $-228.0K | $-550.0K | $55.0K | $-74.0K | $41.0K | $160.0K | |
| Pretax Income | $96M | $-22M | $20M | $-63M | $-56M | $-26M | $3M | $20M | $16M | $9M | $22M | $19M | |
| Income Tax | $17M | $-4M | $1M | $-15M | $-13M | $-3M | $-3M | $5M | $17M | $5M | $6M | $-9M | |
| Net Income | $78M | $-19M | $19M | $-48M | $-43M | $-23M | $6M | $15M | $-1M | $4M | $15M | $29M | |
| EPS (Basic) | $3.50 | $-1.04 | $0.86 | $-3.05 | $-3.40 | $-1.88 | $0.51 | $1.31 | $-0.09 | $0.34 | $1.34 | $2.61 | |
| EPS (Diluted) | $3.32 | $-1.04 | $0.85 | $-3.05 | $-3.40 | $-1.88 | $0.50 | $1.30 | $-0.09 | $0.34 | $1.32 | $2.59 | |
| Shares (Basic) | 20,053,000 | 19,318,000 | 18,001,000 | 16,260,000 | 12,596,000 | 11,964,000 | 11,841,000 | 11,677,000 | 11,547,000 | 11,445,000 | 11,370,000 | 10,941,000 | |
| Shares (Diluted) | 21,228,000 | 19,318,000 | 18,194,000 | 16,260,000 | 12,596,000 | 11,964,000 | 12,040,000 | 11,772,000 | 11,547,000 | 11,573,000 | 11,557,000 | 11,053,000 | |
| EBITDA | $111M | $584.0K | $47M | $-35M | $7M | $29M | $61M | $69M | $56M | $42M | $40M | $24M |
Bilans
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $286M | $145M | $221M | $48M | $100M | $8M | $62M | $43M | $31M | $27M | $155M | $169M | |
| Receivables | $281M | $222M | $162M | $165M | $129M | $96M | $72M | $65M | $59M | $46M | $22M | $17M | |
| Inventory | $143M | $137M | $111M | $105M | $82M | $61M | $48M | $41M | $38M | $26M | $13M | $8M | |
| Prepaid Expense | $34M | $18M | $17M | $8M | $8M | $6M | $4M | $5M | $3M | $4M | $1M | $1M | |
| Current Assets | $753M | $528M | $520M | $344M | $322M | $170M | $188M | $153M | $132M | $103M | $193M | $195M | |
| PP&E (Net) | $62M | $57M | $45M | $43M | $53M | $41M | $41M | $38M | $20M | $11M | $7M | $5M | |
| PP&E (Gross) | · | · | $78M | $76M | $76M | $59M | $53M | $46M | $27M | $16M | $12M | $9M | |
| Accum. Depreciation | · | · | $33M | $33M | $23M | $18M | $13M | $8M | $7M | $5M | $4M | $4M | |
| Goodwill | $62M | $60M | $28M | $28M | $28M | $4M | $4M | $4M | $2M | $2M | $2M | $2M | |
| Intangibles | $480M | $542M | $209M | $252M | $294M | $189M | $180M | $202M | $230M | $176M | $66M | $42M | |
| Other Non-current Assets | $14M | $12M | $12M | $11M | $2M | $802.0K | $1M | $1M | $829.0K | $0 | · | · | |
| Total Assets | $1.44B | $1.28B | $904M | $760M | $772M | $461M | $457M | $431M | $412M | $323M | $285M | $260M | |
| Accounts Payable | $63M | $46M | $37M | $29M | $23M | $11M | $15M | $9M | $4M | $3M | $2M | $3M | |
| Accrued Liabilities | $17M | $14M | $6M | $5M | $8M | $2M | $2M | $2M | $2M | $927.0K | $617.0K | $567.0K | |
| Current Liabilities | $278M | $194M | $145M | $99M | $88M | $79M | $62M | $166M | $39M | $32M | $12M | $13M | |
| Capital Leases | $9M | $4M | $4M | $1M | $995.0K | $172.0K | $292.0K | · | · | · | · | · | |
| Other Non-current Liabilities | $12M | $6M | $5M | $1M | $8M | $14M | $7M | $496.0K | $0 | · | · | · | |
| Total Liabilities | $900M | $856M | $447M | $422M | $413M | $265M | $244M | $233M | $237M | $153M | $125M | $120M | |
| Long-term Debt | $309M | $318M | $286M | $287M | $287M | $186M | $186M | $71M | $128M | $121M | $113M | $107M | |
| Total Debt | $309M | $318M | $286M | $287M | $287M | $186M | $186M | $71M | $73M | · | · | · | |
| Common Stock | $3.0K | $2.0K | $2.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | |
| Paid-in Capital | $596M | $520M | $514M | $404M | $388M | $214M | $201M | $187M | $179M | $173M | $164M | $160M | |
| Retained Earnings | $-23M | $-100M | $-80M | $-97M | $-48M | $-5M | $18M | $11M | $-4M | $-3M | $-4M | $-20M | |
| Treasury Stock | $33M | $21M | $10M | $5M | $3M | $2M | $723.0K | $659.0K | $259.0K | $0 | · | $0 | |
| AOCI | $1M | $5M | $9M | $12M | $-3M | $-11M | $-5M | $-379.0K | $0 | · | · | · | |
| Stockholders' Equity | $541M | $404M | $433M | $314M | $334M | $196M | $213M | $197M | $175M | $170M | $160M | $140M | |
| Liabilities + Equity | $1.44B | $1.28B | $904M | $760M | $772M | $461M | $457M | $431M | $412M | $323M | $285M | $260M | |
| Shares Outstanding | 23,113,000 | 21,538,000 | 20,731,000 | 17,644,000 | 16,913,000 | 12,354,398 | 12,089,565 | 11,851,329 | 11,650,565 | 11,588,701 | 11,498,228 | 11,387,860 |
Przepływy pieniężne
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $91M | $68M | $60M | $57M | $47M | $45M | $45M | $34M | $28M | $22M | $7M | $4M | |
| Stock-based Comp | $38M | $29M | $21M | $15M | $10M | $13M | $9M | $7M | $6M | $6M | $4M | $3M | |
| Deferred Tax | $12M | $-23M | $-12M | $-15M | $-17M | $-13M | $-7M | $-5M | $4M | $-9M | $-2M | $2M | |
| Amort. of Intangibles | $82M | $60M | $52M | $50M | $42M | $40M | $40M | $32M | $27M | $21M | $6M | $3M | |
| Other Non-cash | · | · | · | · | $5M | $-7M | $-7M | $16M | $3M | $4M | $-7M | $-16M | |
| Operating Cash Flow | $185M | $64M | $119M | $-31M | $3M | $15M | $46M | $67M | $39M | $27M | $17M | $22M | |
| CapEx | $14M | $16M | $9M | $9M | $3M | $6M | $7M | $6M | $10M | $5M | $2M | $1M | |
| Investing Cash Flow | $-34M | $-405M | $-19M | $-16M | $-105M | $-68M | $-28M | $-27M | $-108M | $-149M | $-33M | $-36M | |
| Debt Issued | · | · | · | · | · | · | $0 | $0 | $75M | $0 | $0 | · | |
| Net Debt Issued | · | · | · | · | · | · | $0 | $0 | $75M | · | · | · | |
| Stock Issued | $0 | $0 | $81M | $0 | $70M | $0 | $0 | · | · | · | · | · | |
| Stock Repurchased | $12M | $11M | $5M | $2M | $890.0K | $2M | $1M | $0 | $0 | $2M | $0 | $0 | |
| Net Stock Activity | $-12M | $-11M | $76M | $-2M | $74M | · | · | $0 | $0 | $-2M | $-113.0K | $0 | |
| Dividends Paid | $1M | $2M | $2M | $2M | $190.0K | $0 | $0 | · | · | · | · | · | |
| Financing Cash Flow | $-10M | $265M | $67M | $-5M | $195M | $-1M | $1M | $-28M | $72M | $-729.0K | $1M | $172M | |
| Net Change in Cash | $141M | $-76M | $168M | $-52M | $92M | · | · | · | · | $-127M | $-14M | $158M | |
| Taxes Paid | $18M | · | · | · | · | · | · | · | · | $10M | $13M | $147.0K | |
| Free Cash Flow | $171M | $48M | $110M | $-40M | $765.0K | $9M | $39M | $61M | $29M | $23M | $15M | $21M |
Rentowność
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 12.6% | 0.10% | 9.7% | -11.2% | -18.4% | -7.7% | 7.9% | 17.5% | 16.0% | 15.6% | 42.8% | 35.7% | |
| Net Margin | 8.9% | -3.0% | 3.9% | -15.1% | -19.7% | -10.8% | 2.9% | 7.7% | -0.61% | 3.1% | 20.1% | 51.4% | |
| Pretax Margin | 10.8% | -3.6% | 4.1% | -19.8% | -25.9% | -12.4% | 1.5% | 10.0% | 9.2% | 6.8% | 28.5% | 34.6% | |
| EBITDA Margin | 12.6% | 0.10% | 9.7% | -11.2% | 3.5% | 13.7% | 29.5% | 34.3% | 31.8% | 33.0% | 51.9% | 42.7% | |
| ROA | 5.8% | -1.7% | 2.3% | -6.2% | -6.9% | -4.9% | 1.4% | 3.7% | -0.29% | 1.3% | 5.6% | 18.6% | |
| ROE | 16.6% | -4.4% | 5.0% | -14.8% | -16.2% | -11.5% | 2.9% | 8.0% | -0.62% | 2.4% | 10.2% | 31.8% | |
| ROIC | 10.7% | 0.07% | 6.2% | -4.5% | -4.9% | -3.6% | 7.9% | 10.2% | -0.75% | 5.4% | 14.4% | 21.2% |
Płynność i wypłacalność
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 2.7 | 2.7 | 3.6 | 3.5 | 3.7 | 2.2 | 3.0 | 0.9 | 3.4 | 3.2 | 16.4 | 15.4 | |
| Quick Ratio | 2.0 | 1.9 | 2.6 | 2.1 | 2.6 | 1.3 | 2.2 | 0.7 | 2.3 | 2.3 | 15.0 | 14.1 | |
| Debt / Equity | 0.6 | 0.8 | 0.7 | 0.9 | 0.9 | 0.9 | 0.9 | 0.4 | 0.4 | · | · | · | |
| LT Debt / Equity | 0.5 | 0.8 | 0.7 | 0.9 | 0.9 | 0.9 | 0.8 | 0.3 | 0.4 | · | · | · |
Efektywność
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.6 | 0.6 | 0.6 | 0.4 | 0.4 | 0.5 | 0.5 | 0.5 | 0.5 | 0.4 | 0.3 | 0.4 | |
| Inventory Turnover | · | · | · | · | · | 1.6 | 1.4 | 1.9 | 2.5 | 2.5 | 1.2 | 2.1 | |
| Receivables Turnover | 3.5 | 3.2 | 3.0 | 2.2 | 1.9 | 2.5 | 3.0 | 3.3 | 3.4 | 3.8 | 3.9 | 3.8 |
Na akcję
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $24.04 | $18.74 | $21.14 | $17.93 | $19.76 | $15.84 | $17.60 | $16.64 | $15.00 | $14.64 | $13.92 | $12.27 | |
| Revenue / Share | $41.61 | $31.80 | $26.76 | $19.46 | $17.16 | $17.43 | $17.16 | $17.12 | $15.31 | $11.11 | $6603.96 | $5.06 | |
| Cash Flow / Share | $8.73 | $3.31 | $6.54 | $-1.92 | $0.26 | $1.28 | $3.79 | $5.70 | $3.41 | $2.37 | $1493.81 | $1.99 | |
| Cash / Share | $12.70 | $6.73 | $10.80 | $2.76 | $5.93 | $0.64 | $5.16 | $3.63 | $2.67 | $2.36 | $13.45 | $14.84 | |
| EPS (TTM) | $3.32 | $-1.04 | $0.85 | $-3.05 | $-3.40 | $-1.88 | $0.50 | $1.30 | $-0.09 | $0.34 | $1.32 | $2.59 |
Stopy Wzrostu
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 43.8% | 26.2% | 53.9% | 46.4% | 3.7% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 40.8% | 41.7% | 32.7% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 33.5% | · | · | · | · | · | · | · | · | · | · | · |
Wycena (TTM)
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $883M | $614M | $487M | $316M | $216M | $208M | $207M | $202M | $177M | $129M | $76M | $56M | |
| Net Income TTM | $78M | $-19M | $19M | $-48M | $-43M | $-23M | $6M | $15M | $-1M | $4M | $15M | $29M | |
| Market Cap | $1.78B | $1.19B | $1.13B | $704M | $779M | $359M | $746M | $534M | $751M | $703M | $519M | $642M | |
| Enterprise Value | $1.80B | $1.36B | $1.19B | $942M | $966M | $537M | $869M | $561M | $793M | · | · | · | |
| P/E | 23.8 | -53.2 | 64.9 | -13.2 | -13.6 | -15.4 | 123.3 | 34.6 | -716.1 | 178.3 | 34.2 | 21.8 | |
| P/S | 2.0 | 1.9 | 2.3 | 2.2 | 3.6 | 1.7 | 3.6 | 2.6 | 4.2 | 5.5 | 6.8 | 11.5 | |
| P/B | 3.3 | 2.9 | 2.6 | 2.2 | 2.3 | 1.8 | 3.5 | 2.7 | 4.3 | 4.1 | 3.2 | 4.6 | |
| P / Tangible Book | · | · | 5.8 | 20.8 | 65.6 | 99.4 | · | · | · | · | · | · | |
| P / Cash Flow | 9.6 | 18.6 | 9.5 | -22.6 | 234.4 | 23.5 | 16.3 | 8.0 | 19.0 | 25.6 | 30.1 | 29.1 | |
| P / FCF | 10.4 | 24.9 | 10.3 | -17.6 | 1018.0 | 39.3 | 19.1 | 8.7 | 25.8 | 30.7 | 34.4 | 30.7 | |
| EV / EBITDA | 16.2 | 2335.7 | 25.4 | -26.7 | 129.5 | 18.7 | 14.3 | 8.1 | 14.1 | · | · | · | |
| EV / FCF | 10.5 | 28.5 | 10.8 | -23.5 | 1262.5 | 58.8 | 22.3 | 9.1 | 27.3 | · | · | · | |
| EV / Revenue | 2.0 | 2.2 | 2.5 | 3.0 | 4.5 | 2.6 | 4.2 | 2.8 | 4.5 | · | · | · | |
| Dividend Yield | 0.07% | 0.14% | 0.14% | 0.23% | 0.02% | 0.00% | 0.00% | · | · | · | · | · | |
| Earnings Yield | 4.2% | -1.9% | 1.5% | -7.6% | -7.4% | -6.5% | 0.81% | 2.9% | -0.14% | 0.56% | 2.9% | 4.6% | |
| Payout Ratio | 1.5% | -8.8% | 8.6% | -3.4% | -0.45% | · | · | · | · | · | · | · | |
| Annual Payout | $1M | $2M | $2M | $2M | $190.0K | $0 | $0 | · | · | · | · | · |
Rachunek zysków i strat
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $266M | $237M | $247M | $228M | $211M | $197M | $191M | $148M | $138M | $137M | $132M | $132M | $117M | $107M | $94M | $84M | |
| R&D Expense | $15M | $11M | $12M | $12M | $17M | $11M | $17M | $10M | $7M | $11M | $10M | $11M | $7M | $6M | $5M | $8M | |
| SG&A Expense | $92M | $74M | $83M | $77M | $82M | $77M | $70M | $79M | $53M | $48M | $44M | $42M | $39M | $36M | $33M | $30M | |
| Operating Expenses | $226M | $199M | $212M | $192M | $197M | $171M | $195M | $169M | $133M | $117M | $125M | $114M | $104M | $97M | $92M | $89M | |
| Operating Income | $40M | $39M | $35M | $36M | $14M | $26M | $-4M | $-21M | $5M | $20M | $7M | $18M | $12M | $10M | $2M | $-5M | |
| Interest Income | $4M | $4M | $4M | $4M | $3M | $3M | $3M | $4M | $4M | $5M | · | · | · | · | · | · | |
| Other Non-op | $-468.0K | $-651.0K | $850.0K | $-853.0K | $2M | $198.0K | $-1M | $-3M | $-88.0K | $-32.0K | $-33.0K | $-39.0K | $-53.0K | $-34.0K | $-42.0K | $37.0K | |
| Pretax Income | $37M | $40M | $31M | $34M | $11M | $20M | $-14M | $-31M | $-2M | $25M | $947.0K | $12M | $5M | $2M | $-6M | $-12M | |
| Income Tax | $12M | $11M | $4M | $7M | $2M | $4M | $-3M | $-7M | $0 | $7M | $-208.0K | $2M | $-996.0K | $726.0K | $-1M | $-4M | |
| Net Income | $25M | $29M | $27M | $27M | $9M | $16M | $-10M | $-24M | $-2M | $18M | $1M | $10M | $6M | $1M | $-4M | $-9M | |
| EPS (Basic) | $1.09 | $1.31 | $1.24 | $1.19 | $0.37 | $0.70 | $-0.47 | $-1.27 | $-0.14 | $0.84 | $0.04 | $0.46 | $0.30 | $0.06 | $-0.29 | $-0.55 | |
| EPS (Diluted) | $1.05 | $1.28 | $1.14 | $1.13 | $0.36 | $0.69 | $-0.45 | $-1.27 | $-0.14 | $0.82 | $0.05 | $0.45 | $0.29 | $0.06 | $-0.29 | $-0.55 | |
| Shares (Basic) | 21,158,000 | 20,914,000 | · | 20,074,000 | 19,834,000 | 19,607,000 | · | 19,404,000 | 19,321,000 | 19,099,000 | · | 18,883,000 | 17,688,000 | 16,392,000 | · | 16,303,000 | |
| Shares (Diluted) | 21,915,000 | 21,544,000 | · | 21,093,000 | 20,308,000 | 20,046,000 | · | 19,404,000 | 19,321,000 | 19,422,000 | · | 19,125,000 | 17,855,000 | 16,531,000 | · | 16,303,000 | |
| EBITDA | $40M | $39M | · | $36M | $14M | $26M | · | $-21M | $5M | $20M | · | $18M | $12M | $10M | · | $-5M |
Bilans
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $360M | $311M | $286M | $263M | $218M | $150M | $145M | $145M | $240M | $229M | $221M | $193M | $162M | $68M | $48M | $56M | |
| Receivables | $274M | $255M | $281M | $253M | $226M | $220M | $222M | $196M | $166M | $172M | · | $179M | $173M | $175M | · | $140M | |
| Inventory | $143M | $143M | $143M | $146M | $138M | $137M | $137M | $148M | $125M | $114M | · | $107M | $104M | $104M | · | $96M | |
| Prepaid Expense | $32M | $22M | $23M | $19M | $15M | $23M | $18M | $17M | $14M | $16M | · | $11M | $8M | $7M | · | $5M | |
| Current Assets | $825M | $747M | $753M | $698M | $603M | $536M | $528M | $521M | $555M | $541M | · | $497M | $459M | $365M | · | $309M | |
| PP&E (Net) | $73M | $67M | $62M | $64M | $59M | $58M | $57M | $57M | $52M | $49M | · | $44M | $44M | $43M | · | $43M | |
| PP&E (Gross) | · | · | · | · | · | · | · | · | · | · | · | · | · | $71M | · | $73M | |
| Accum. Depreciation | · | · | · | · | · | · | · | · | · | · | · | · | · | $27M | · | $30M | |
| Goodwill | $62M | $62M | $62M | $62M | $61M | $61M | $60M | $60M | $28M | $28M | · | $28M | $28M | $28M | · | $28M | |
| Intangibles | $450M | $467M | $480M | $500M | $520M | $538M | $542M | $570M | $183M | $196M | · | $220M | $230M | $239M | · | $264M | |
| Other Non-current Assets | $12M | $12M | $14M | $12M | $8M | $10M | $12M | $11M | $13M | $14M | · | $16M | $16M | $9M | · | $12M | |
| Total Assets | $1.49B | $1.42B | $1.44B | $1.41B | $1.34B | $1.29B | $1.28B | $1.29B | $921M | $915M | · | $890M | $859M | $765M | · | $739M | |
| Accounts Payable | $74M | $70M | $63M | $70M | $55M | $53M | $46M | $61M | $49M | $49M | · | $34M | $29M | $33M | · | $19M | |
| Accrued Liabilities | $17M | $14M | $17M | $14M | $15M | $12M | $14M | $18M | $7M | $7M | · | $5M | $5M | $5M | · | $5M | |
| Current Liabilities | $284M | $240M | $278M | $271M | $237M | $202M | $194M | $190M | $140M | $137M | · | $134M | $123M | $126M | · | $82M | |
| Capital Leases | · | · | $9M | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Other Non-current Liabilities | $16M | $16M | $12M | $11M | $7M | $7M | $6M | $7M | $5M | $5M | · | $5M | $5M | $1M | · | $1M | |
| Total Liabilities | $897M | $860M | $900M | $902M | $881M | $849M | $856M | $857M | $440M | $438M | · | $435M | $425M | $426M | · | $402M | |
| Long-term Debt | $301M | $305M | $309M | $313M | $315M | $316M | $318M | $320M | $285M | $285M | · | $286M | $286M | $286M | · | $287M | |
| Total Debt | $301M | $305M | · | $313M | $315M | $316M | · | $320M | $285M | $285M | · | $286M | $286M | $286M | · | $287M | |
| Common Stock | $3.0K | $3.0K | $3.0K | $3.0K | $2.0K | $2.0K | $2.0K | $2.0K | $2.0K | $2.0K | · | $2.0K | $2.0K | $1.0K | · | $1.0K | |
| Paid-in Capital | $620M | $608M | $596M | $586M | $542M | $531M | $520M | $511M | $532M | $524M | · | $507M | $495M | $408M | · | $399M | |
| Retained Earnings | $31M | $6M | $-23M | $-51M | $-77M | $-85M | $-100M | $-90M | $-65M | $-62M | · | $-81M | $-90M | $-96M | · | $-93M | |
| Treasury Stock | $54M | $53M | $33M | $33M | $32M | $31M | $21M | $21M | $20M | $19M | · | $10M | $9M | $9M | · | $5M | |
| AOCI | $-327.0K | $479.0K | $1M | $3M | $3M | $4M | $5M | $5M | $8M | $9M | · | $14M | $14M | $11M | · | $10M | |
| Stockholders' Equity | $597M | $562M | $541M | $506M | $437M | $419M | $404M | $406M | $456M | $452M | · | $430M | $410M | $315M | · | $312M | |
| Liabilities + Equity | $1.49B | $1.42B | $1.44B | $1.41B | $1.34B | $1.29B | $1.28B | $1.29B | $921M | $915M | · | $890M | $859M | $765M | · | $739M | |
| Shares Outstanding | 23,853,000 | 23,759,000 | 22,491,281 | 23,076,000 | 22,322,000 | 22,255,000 | 21,108,152 | 21,494,000 | 21,476,000 | 21,373,000 | 20,731,000 | 20,654,000 | 20,287,425 | 17,992,397 | 17,644,000 | 17,467,920 |
Przepływy pieniężne
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $20M | $21M | $23M | $23M | $23M | $23M | $23M | $16M | $15M | $15M | $15M | $15M | $15M | $15M | $14M | $14M | |
| Stock-based Comp | $11M | $10M | $10M | $10M | $10M | $9M | $7M | $7M | $8M | $7M | $6M | $5M | $5M | $4M | $4M | $4M | |
| Amort. of Intangibles | $17M | $19M | $20M | $20M | $21M | $21M | $20M | $14M | $13M | $13M | $13M | $13M | $13M | $13M | $13M | $12M | |
| Operating Cash Flow | $57M | $58M | $30M | $44M | $76M | $35M | $16M | $12M | $17M | $18M | $45M | $32M | $21M | $21M | $-4M | $4M | |
| CapEx | $3M | $6M | $1M | $6M | $4M | $2M | $2M | $5M | $4M | $5M | $2M | $2M | $3M | $2M | $3M | $2M | |
| Investing Cash Flow | $-3M | $-11M | $-1M | $-6M | $-7M | $-20M | $-11M | $-399M | $-4M | $9M | $-5M | $-5M | $-7M | $-2M | $-3M | $-10M | |
| Stock Issued | · | · | · | · | · | · | $0 | $0 | · | · | $0 | $0 | · | · | $0 | $0 | |
| Stock Repurchased | $813.0K | $20M | $611.0K | $1M | $551.0K | $10M | $318.0K | $680.0K | $1M | $9M | $231.0K | $670.0K | $537.0K | $4M | $119.0K | $239.0K | |
| Net Stock Activity | · | $-20M | · | · | · | $-10M | · | · | · | $-9M | · | · | · | $-4M | · | · | |
| Dividends Paid | $0 | $0 | $0 | $344.0K | $407.0K | $406.0K | $406.0K | $406.0K | $407.0K | $406.0K | $406.0K | $406.0K | $407.0K | $406.0K | $407.0K | $406.0K | |
| Financing Cash Flow | $-5M | $-22M | $-5M | $6M | $-2M | $-10M | $-5M | $291M | $-1M | $-20M | $-12M | $4M | $80M | $-5M | $-508.0K | $-911.0K | |
| Net Change in Cash | $49M | $26M | $23M | $45M | $68M | $5M | $-123.0K | $-95M | $12M | $7M | $28M | $31M | $94M | $15M | $-8M | $-7M | |
| Taxes Paid | $19M | $-6M | · | · | $16M | $285.0K | · | · | · | · | · | · | · | · | · | · | |
| Free Cash Flow | · | $52M | · | · | · | $33M | · | · | · | $14M | · | · | · | $19M | · | · |
Rentowność
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 15.2% | 16.4% | · | 15.9% | 6.6% | 13.3% | · | -13.8% | 3.7% | 14.8% | · | 13.6% | 10.6% | 9.3% | · | -6.0% | |
| Net Margin | 9.3% | 12.4% | · | 11.7% | 4.0% | 8.0% | · | -16.3% | -1.7% | 13.2% | · | 7.5% | 5.4% | 1.4% | · | -10.3% | |
| Pretax Margin | 13.9% | 16.9% | · | 14.8% | 5.0% | 10.1% | · | -21.2% | -1.7% | 18.4% | · | 8.7% | 4.5% | 2.0% | · | -14.6% | |
| EBITDA Margin | 15.2% | 16.4% | · | 15.9% | 6.6% | 13.3% | · | -13.8% | 3.7% | 14.8% | · | 13.6% | 10.6% | 9.3% | · | -6.0% | |
| ROA | 1.7% | 2.2% | · | 2.0% | 0.76% | 1.4% | · | -2.2% | -0.26% | 2.2% | · | 1.2% | 0.78% | 0.19% | · | -1.4% | |
| ROE | 4.8% | 6.0% | · | 5.8% | 1.9% | 3.6% | · | -5.8% | -0.53% | 4.8% | · | 2.7% | 1.7% | 0.45% | · | -3.4% | |
| ROIC | 3.0% | 3.3% | · | 3.5% | 1.5% | 2.8% | · | -2.2% | 0.70% | 2.0% | · | 2.2% | 2.1% | 1.1% | · | -0.59% |
Płynność i wypłacalność
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 2.9 | 3.1 | · | 2.6 | 2.5 | 2.7 | · | 2.7 | 4.0 | 3.9 | · | 3.7 | 3.7 | 2.9 | · | 3.8 | |
| Quick Ratio | 2.2 | 2.4 | · | 1.9 | 1.9 | 1.8 | · | 1.8 | 2.9 | 2.9 | · | 2.8 | 2.7 | 1.9 | · | 2.4 | |
| Debt / Equity | 0.5 | 0.5 | · | 0.6 | 0.7 | 0.8 | · | 0.8 | 0.6 | 0.6 | · | 0.7 | 0.7 | 0.9 | · | 0.9 | |
| LT Debt / Equity | 0.5 | 0.5 | · | 0.6 | 0.7 | 0.7 | · | 0.8 | 0.6 | 0.6 | · | 0.7 | 0.7 | 0.9 | · | 0.9 |
Efektywność
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.1 | 0.2 | 0.2 | · | 0.2 | 0.1 | 0.1 | · | 0.1 | |
| Receivables Turnover | 1.1 | 1.0 | · | 1.0 | 1.1 | 1.0 | · | 0.8 | 0.8 | 0.8 | · | 0.8 | 0.7 | 0.7 | · | 0.7 |
Na akcję
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $25.04 | $23.67 | · | $21.92 | $19.57 | $18.81 | · | $18.89 | $21.22 | $21.15 | · | $20.81 | $20.19 | $17.49 | · | $17.85 | |
| Revenue / Share | $12.14 | $11.02 | · | $10.80 | $10.41 | $9.83 | · | $7.64 | $7.14 | $7.08 | · | $6.89 | $6.53 | $6.46 | · | $5.14 | |
| Cash Flow / Share | · | $2.71 | · | · | · | $1.75 | · | · | · | $0.94 | · | · | · | $1.30 | · | · | |
| Cash / Share | $15.10 | $13.10 | · | $11.38 | $9.76 | $6.73 | · | $6.75 | $11.18 | $10.70 | · | $9.35 | $7.97 | $3.77 | · | $3.22 | |
| EPS (TTM) | $4.60 | $3.91 | · | $1.73 | $-0.67 | $-1.17 | · | $-0.54 | $1.18 | $1.61 | · | $0.51 | $-0.49 | $-1.72 | · | $-4.63 |
Wycena (TTM)
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $978M | $924M | · | $827M | $747M | $674M | · | $555M | $539M | $517M | · | $449M | $401M | $359M | · | $283M | |
| Net Income TTM | $108M | $92M | · | $41M | $-10M | $-21M | · | $-7M | $27M | $36M | · | $13M | $-5M | $-26M | · | $-68M | |
| Market Cap | $1.97B | $1.83B | · | $2.11B | $1.46B | $1.49B | · | $1.28B | $1.37B | $1.48B | · | $1.20B | $1.09B | $715M | · | $561M | |
| Enterprise Value | $1.92B | $1.82B | · | $2.16B | $1.55B | $1.66B | · | $1.46B | $1.41B | $1.53B | · | $1.29B | $1.22B | $933M | · | $792M | |
| P/E | 18.0 | 19.7 | · | 52.9 | -97.4 | -57.2 | · | -110.5 | 54.0 | 42.9 | · | 113.8 | -109.9 | -23.1 | · | -6.9 | |
| P/S | 2.0 | 2.0 | · | 2.6 | 1.9 | 2.2 | · | 2.3 | 2.5 | 2.9 | · | 2.7 | 2.7 | 2.0 | · | 2.0 | |
| P/B | 3.3 | 3.2 | · | 4.2 | 3.3 | 3.6 | · | 3.2 | 3.0 | 3.3 | · | 2.8 | 2.7 | 2.3 | · | 1.8 | |
| P / Tangible Book | 23.3 | 55.9 | · | · | · | · | · | · | 5.6 | 6.5 | · | 6.6 | 7.2 | 15.0 | · | 29.0 | |
| P / Cash Flow | · | 31.3 | · | · | · | 42.6 | · | · | · | 80.9 | · | · | · | 33.4 | · | · | |
| EV / Revenue | 2.0 | 2.0 | · | 2.6 | 2.1 | 2.5 | · | 2.6 | 2.6 | 3.0 | · | 2.9 | 3.0 | 2.6 | · | 2.8 | |
| Dividend Yield | 0.02% | 0.04% | · | 0.07% | 0.11% | 0.11% | · | 0.13% | 0.12% | 0.11% | · | 0.14% | 0.15% | 0.23% | · | 0.25% | |
| Earnings Yield | 5.6% | 5.1% | · | 1.9% | -1.0% | -1.8% | · | -0.91% | 1.8% | 2.3% | · | 0.88% | -0.91% | -4.3% | · | -14.4% | |
| Payout Ratio | · | 0.00% | · | · | · | 2.6% | · | · | · | 2.2% | · | · | · | 28.2% | · | · | |
| Annual Payout | $344.0K | $751.0K | · | $2M | $2M | $2M | · | $2M | $2M | $2M | · | $2M | $2M | $2M | · | $1M |
Najnowszy okres po lewej · wartości null pokazane jako ·
Sprawozdania finansowe Rachunek zysków i strat, bilans, przepływy pieniężne — roczne, ostatnie 5 lat
| Wskaźnik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Przychody | $883M | $614M | $487M | $316M | $216M |
| Marża Operacyjna % | 12.6% | 0.10% | 9.7% | -11.2% | -18.4% |
| Zysk netto | $78M | $-19M | $19M | $-48M | $-43M |
| Rozwodniony EPS | $3.32 | $-1.04 | $0.85 | $-3.05 | $-3.40 |
| Wskaźnik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Dług / Kapitał Własny | 0.6 | 0.8 | 0.7 | 0.9 | 0.9 |
| Wskaźnik bieżący | 2.7 | 2.7 | 3.6 | 3.5 | 3.7 |
| Wskaźnik Szybkości | 2.0 | 1.9 | 2.6 | 2.1 | 2.6 |
| Wskaźnik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Wolny przepływ pieniężny | $171M | $48M | $110M | $-40M | $765.0K |
Właściciele instytucjonalni (13F) 318 emitentów · $2.0B łącznie · Na dzień 30 września 2026
Instytucje, które zgłaszają posiadanie tych akcji w swoich kwartalnych zgłoszeniach SEC Form 13F. Tylko pozycje długie; pojedynczy zgłaszający może pojawić się dwukrotnie dla oddzielnych transz opcji. Duże przeciwstawne pozycje put/call zazwyczaj odzwierciedlają działalność market-makingową lub zabezpieczone zapasy, a nie przekonanie kierunkowe.
Posiadacze
318
Wartość posiadanych akcji
$2.0B
Nowe pozycje
47
Zamknięte pozycje
24
Aktywność instytucjonalna — Q2 2026 vs poprzedni kwartał
| Nowe pozycje | Zamknięte pozycje | Zwiększone | Zmniejszony | Zmiana liczby akcji netto |
|---|---|---|---|---|
| 47 (-3 vs poprzedni kw.) | 24 (-15 vs poprzedni kw.) | 118 (+8 vs poprzedni kw.) | 91 (+7 vs poprzedni kw.) | -412K |
Porównano z Q1 2026. Zgłoszenia SEC Form 13F są wymagane w ciągu 45 dni od końca kwartału plus krótki bufor dla spóźnionych zgłoszeń — kwartały mieszczące się jeszcze w tym terminie są pomijane na rzecz ostatniej w pełni zgłoszonej pary.
| Instytucja | Wartość | Akcje | % z śledzonych 13F | Typ |
|---|---|---|---|---|
| BlackRock, Inc. | $244 916 714 | 2 958 646 | 12,36% | Akcje |
| VANGUARD GROUP INC | $103 022 068 | 1 305 068 | 5,20% | Akcje |
| Soleus Capital Management, L.P. | $71 833 173 | 867 760 | 3,62% | Akcje |
| VANGUARD CAPITAL MANAGEMENT LLC | $69 388 183 | 838 224 | 3,50% | Akcje |
| STATE STREET CORP | $68 855 281 | 831 647 | 3,47% | Akcje |
| TANG CAPITAL MANAGEMENT LLC | $58 566 850 | 707 500 | 2,96% | Akcje |
| DIMENSIONAL FUND ADVISORS LP | $51 613 558 | 623 463 | 2,60% | Akcje |
| AMERICAN CENTURY COMPANIES INC | $47 554 958 | 574 474 | 2,40% | Akcje |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $46 523 684 | 562 016 | 2,35% | Akcje |
| Global Alpha Capital Management Ltd. | $46 191 488 | 558 003 | 2,33% | Akcje |
| GEODE CAPITAL MANAGEMENT, LLC | $44 411 791 | 536 407 | 2,24% | Akcje |
| MILLENNIUM MANAGEMENT LLC | $41 986 595 | 507 207 | 2,12% | Akcje |
| Nuveen, LLC | $34 355 687 | 415 024 | 1,73% | Akcje |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $33 714 721 | 407 281 | 1,70% | Akcje |
| Ranger Investment Management, L.P. | $28 405 957 | 343 150 | 1,43% | Akcje |
| DEUTSCHE BANK AG\ | $26 774 611 | 323 443 | 1,35% | Akcje |
| Invesco Ltd. | $25 598 308 | 309 233 | 1,29% | Akcje |
| UBS Group AG | $24 630 278 | 297 539 | 1,24% | Akcje |
| KENNEDY CAPITAL MANAGEMENT LLC | $24 497 748 | 295 938 | 1,24% | Akcje |
| AMERIPRISE FINANCIAL INC | $23 789 485 | 287 382 | 1,20% | Akcje |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | $23 775 000 | 287 206 | 1,20% | Akcje |
| Ikarian Capital, LLC | $22 523 196 | 272 085 | 1,14% | Akcje |
| Aberdeen Group plc | $22 496 293 | 271 760 | 1,14% | Akcje |
| OBERWEIS ASSET MANAGEMENT INC/ | $21 962 031 | 265 306 | 1,11% | Akcje |
| WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC | $21 371 561 | 258 173 | 1,08% | Akcje |
| Rubric Capital Management LP | $21 368 084 | 258 131 | 1,08% | Akcje |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $20 908 076 | 252 574 | 1,06% | Akcje |
| JPMORGAN CHASE & CO | $19 678 454 | 232 954 | 0,99% | Akcje |
| NOMURA HOLDINGS INC | $19 366 795 | 233 955 | 0,98% | Akcje |
| Jones Hill Capital LP | $19 354 626 | 233 808 | 0,98% | Akcje |
| BANK OF MONTREAL /CAN/ | $18 601 245 | 224 707 | 0,94% | Akcje |
| TEACHER RETIREMENT SYSTEM OF TEXAS | $18 214 084 | 220 030 | 0,92% | Akcje |
| ROYAL BANK OF CANADA | $17 565 000 | 212 192 | 0,89% | Akcje |
| MORGAN STANLEY | $17 480 514 | 211 167 | 0,88% | Akcje |
| MIZUHO MARKETS AMERICAS LLC | $17 354 330 | 209 644 | 0,88% | Akcje |
| NORTHERN TRUST CORP | $17 314 513 | 209 163 | 0,87% | Akcje |
| Penn Capital Management Company, LLC | $17 182 509 | 207 362 | 0,87% | Akcje |
| Parkman Healthcare Partners LLC | $16 796 641 | 202 907 | 0,85% | Akcje |
| Caption Management, LLC | $16 556 000 | 200 000 | 0,84% | Opcja sprzedaży |
| Qube Research & Technologies Ltd | $15 971 987 | 192 945 | 0,81% | Akcje |
| BANK OF AMERICA CORP /DE/ | $15 154 203 | 183 066 | 0,76% | Akcje |
| GOLDMAN SACHS GROUP INC | $15 085 496 | 182 236 | 0,76% | Akcje |
| D. E. Shaw & Co., Inc. | $14 464 315 | 174 732 | 0,73% | Akcje |
| LOOMIS SAYLES & CO L P | $13 475 922 | 162 792 | 0,68% | Akcje |
| NEW YORK STATE COMMON RETIREMENT FUND | $12 830 486 | 154 995 | 0,65% | Akcje |
| Russell Investments Group, Ltd. | $11 472 443 | 138 588 | 0,58% | Akcje |
| CITIGROUP INC | $11 292 103 | 136 411 | 0,57% | Akcje |
| PRINCIPAL FINANCIAL GROUP INC | $11 105 019 | 134 151 | 0,56% | Akcje |
| VANGUARD FIDUCIARY TRUST CO | $11 058 332 | 133 587 | 0,56% | Akcje |
| RAYMOND JAMES FINANCIAL INC | $10 866 530 | 131 270 | 0,55% | Akcje |
Aktywiści i właściciele 5%+ 7 akcji
Inwestorzy, którzy złożyli SEC Schedule 13D — posiadanie beneficjentów powyżej 5% z zamiarem wpływania na emitenta (udziały aktywistów, kampanie zarządu, M&A). Każdy wiersz pokazuje najnowszy znany stan pozycji tego zgłaszającego.
| Zgłaszający | Złożono | Udział | Status | Cel | Zgłoszenie |
|---|---|---|---|---|---|
| Meridian Venture Partners II GP, L.P. ("GP"), Meridian Venture Partners II, L.P., Meridian Venture Partners II, Co., Robert E. Brown, Jr. ×2 zgłoszenia | 22 sierpnia 2025 | 4,80% | Aneks | · | SEC |
| Meridian Venture Partners II GP, L.P. (“GP”), Meridian Venture Partners II, L.P. (“MVP II”), Meridian Venture Partners II, Co. (“MVP Corp.”), Robert E. Brown, Jr. ×9 zgłoszenia | 14 marca 2024 | · | Pierwotne zgłoszenie | Inwestycja pasywna | SEC |
| Esjay LLC, SS Pharma LLC, Muthusamy Shanmugam ×3 zgłoszenia | 17 stycznia 2024 | · | Pierwotne zgłoszenie | M&A / sprzedaż | SEC |
| Kopp Investment Advisors, LLC 2), Kopp Holding Company, LLC 2), LeRoy C. Kopp 2) ×4 zgłoszenia | 9 grudnia 2011 | · | Pierwotne zgłoszenie | Inwestycja pasywna | SEC |
| Stephen M. Simes | 13 grudnia 2004 | · | Pierwotne zgłoszenie | · | SEC |
| Niezgłoszona osoba raportująca | 14 lutego 2002 | · | Pierwotne zgłoszenie | · | SEC |
| Niezgłoszona osoba raportująca | 22 sierpnia 2001 | · | Pierwotne zgłoszenie | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Insiderzy spółki 41 insiderów · 14 dyrektorzy generalni · 18 dyrektorzy
| Insider | Rola | Ostatnia aktywność | Posiadane akcje | Kupna 12m | Sprzedaże 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Nikhil Lalwani | PRESIDENT & CEO | 15 września 2026 S | 339 089 | 0 | 3 | $-5 050 970 |
| Arthur Przybyl | President and CEO | 7 kwietnia 2020 F | 190 309 | 0 | 0 | $0 |
| Stephen P. Carey | SVP & CFO | 29 września 2026 S | 168 993 | 0 | 8 | $-1 989 057 |
| Charlotte C. Arnold | Vice President and CFO | 7 kwietnia 2016 A | 54 298 | 0 | 0 | $0 |
| Muthusamy Shanmugam | HEAD OF R&D, COO-NOVITIUM OPS | 26 lutego 2026 A | 101 056 | 0 | 0 | $0 |
| Meredith Cook | SR. VP, GENERAL COUNSEL & SEC. | 14 września 2026 S | 73 924 | 0 | 12 | $-453 872 |
| Ori Gutwerg | SVP, GENERICS | 10 sierpnia 2026 S | 75 534 | 0 | 3 | $-621 438 |
| Thomas Andrew Rowland | SVP, HEAD - ESTABLISHED BRANDS | 12 maja 2026 S | 38 271 | 0 | 2 | $-393 828 |
| Christopher Mutz | HEAD OF RARE DISEASE | 13 marca 2026 S | 91 309 | 0 | 6 | $-1 635 601 |
| Krista Davis | SVP, CHIEF HR OFFICER | 9 marca 2026 S | 51 946 | 0 | 5 | $-918 623 |
| Chad Gassert | SVP - CORP. DEV. & STRATEGY | 28 lutego 2026 F | 74 916 | 0 | 2 | $-1 312 435 |
| James G. Marken | SVP OPS & PROD DEV | 7 czerwca 2024 M | 117 829 | 0 | 0 | $0 |
| Robert W Schrepfer | SVP - NEW BUS DEV & SPEC SALES | 29 marca 2021 F | 87 477 | 0 | 0 | $0 |
| Robert J. Jamnick | VP, Quality & Product Develop. | 22 maja 2014 A | 48 118 | 0 | 0 | $0 |
| Jeanne Thoma | Dyrektor | 11 września 2026 S | 26 762 | 0 | 1 | $-71 530 |
| Henry O Gosebruch | Dyrektor | 19 sierpnia 2026 A | 6 662 | 0 | 0 | $0 |
| Thomas Haughey | Dyrektor | 8 czerwca 2026 S | 38 878 | 0 | 1 | $-161 760 |
| Matthew J Leonard | Dyrektor | 21 maja 2026 A | 11 221 | 0 | 0 | $0 |
| Antonio R Pera | Dyrektor | 21 maja 2026 A | 27 017 | 0 | 0 | $0 |
| Renee P Tannenbaum | Dyrektor | 21 maja 2026 A | 29 514 | 0 | 1 | $-146 070 |
| Patrick D Walsh | Dyrektor | 13 maja 2026 S | 38 432 | 0 | 4 | $-2 323 404 |
| David Nash | Dyrektor | 23 maja 2023 A | 38 561 | 0 | 0 | $0 |
| Robert E. Brown, Jr. | Dyrektor | 27 kwietnia 2022 A | 49 021 | 0 | 0 | $0 |
| Thomas A. Penn | Dyrektor | 28 marca 2019 A | 14 301 | 0 | 0 | $0 |
| Tracy Marshbanks | Dyrektor | 16 maja 2018 S | 349 934 | 0 | 0 | $0 |
| Fred Holubow | Dyrektor | 20 marca 2018 M | 14 811 | 0 | 0 | $0 |
| Daniel Raynor | Dyrektor | 19 marca 2018 S | 289 003 | 0 | 0 | $0 |
| Peter A Lankau | Dyrektor | 7 kwietnia 2016 A | 2 500 | 0 | 0 | $0 |
| Ross J Mangano | Dyrektor | 15 września 2014 P | 26 914 | 0 | 0 | $0 |
| Edward C Rosenow III | · | 30 marca 2012 A | 20 540 | 0 | 0 | $0 |
| John T Potts JR | · | 30 marca 2012 A | 5 581 | 0 | 0 | $0 |
| Louis W Sullivan | · | 30 marca 2012 A | 47 898 | 0 | 0 | $0 |
| SHERWIN STEPHEN A | · | 30 marca 2012 A | 86 760 | 0 | 0 | $0 |
| Michael C Snabes | · | 25 stycznia 2012 A | · | 0 | 0 | $0 |
| Phillip B. Donenberg | · | 25 stycznia 2012 A | 44 322 | 0 | 0 | $0 |
| Stephen M Simes | · | 25 stycznia 2012 A | 202 167 | 0 | 0 | $0 |
| Peter Kjaer | · | 31 marca 2010 A | 34 425 | 0 | 0 | $0 |
| Victor A Morgenstern | · | 28 września 2006 P | 455 571 | 0 | 0 | $0 |
| Steven J Bell | · | 19 lipca 2005 A | 875 | 0 | 0 | $0 |
| Leah M Lehman | · | 19 lipca 2005 A | 0 | 0 | 0 | $0 |
| Angela Ho | · | 18 marca 2004 A | 72 137 | 0 | 0 | $0 |
Insiderzy z zgłoszeń SEC Form 3/4/5; netto = tylko otwarty rynek P/S
Posiadanie ETF-ów Posiadane przez 51 funduszy ETF
Waga odzwierciedla wyłącznie bezpośrednie udziały kapitałowe (N-PORT); fundusze oparte na dźwigni lub instrumentach pochodnych mogą posiadać dodatkowe ekspozycje na swapy, które nie są pokazane.
| Fundusz | Waga | Jednostki | Na dzień | Źródło |
|---|---|---|---|---|
| PJP · Invesco Exchange-Traded Fund Trust | 3,08% | 236 348 SH | 1 października 2026 | Dziennie |
| PILL · Direxion Shares ETF Trust | 1,10% | 2 870 NS | 31 lipca 2026 | N-PORT |
| RZG · Invesco Exchange-Traded Fund Trust | 1,03% | 16 840 SH | 1 października 2026 | Dziennie |
| PSCH · Invesco Exchange-Traded Fund Trust … | 0,79% | 19 407 SH | 1 października 2026 | Dziennie |
| CAFG · Pacer Funds Trust | 0,57% | 2 163 NS | 31 lipca 2026 | N-PORT |
| JSMD · Janus Detroit Street Trust | 0,55% | 72 995 NS | 31 lipca 2026 | N-PORT |
| FYC · First Trust Exchange-Traded AlphaDE… | 0,38% | 62 407 NS | 31 lipca 2026 | N-PORT |
| IHE · iShares Trust | 0,30% | 67 361 SH | 11 września 2026 | Dziennie |
| JPSE · J.P. Morgan Exchange-Traded Fund Tr… | 0,21% | 15 489 NS | 31 lipca 2026 | N-PORT |
| SMDX · Tidal Trust III | 0,20% | 3 327 NS | 31 lipca 2026 | N-PORT |
| CALF · Pacer Funds Trust | 0,17% | 78 799 NS | 31 lipca 2026 | N-PORT |
| VIOG · VANGUARD ADMIRAL FUNDS | 0,17% | 21 706 SH | 19 sierpnia 2026 | Dziennie |
| FYX · First Trust Exchange-Traded AlphaDE… | 0,12% | 21 076 NS | 31 lipca 2026 | N-PORT |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 0,11% | 1 611 SH | 1 października 2026 | Dziennie |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,10% | 22 037 SH | 19 sierpnia 2026 | Dziennie |
| IWO · iShares Trust | 0,10% | 191 714 SH | 11 września 2026 | Dziennie |
| FSMD · FIDELITY COVINGTON TRUST | 0,09% | 28 969 NS | 31 lipca 2026 | N-PORT |
| VFMF · VANGUARD WELLINGTON FUND | 0,09% | 7 952 SH | 19 sierpnia 2026 | Dziennie |
| QVMS · Invesco Exchange-Traded Fund Trust … | 0,09% | 2 851 SH | 1 października 2026 | Dziennie |
| VIOO · VANGUARD ADMIRAL FUNDS | 0,08% | 63 946 SH | 19 sierpnia 2026 | Dziennie |
| FAD · First Trust Exchange-Traded AlphaDE… | 0,08% | 5 654 NS | 31 lipca 2026 | N-PORT |
| BBSC · J.P. Morgan Exchange-Traded Fund Tr… | 0,07% | 5 805 NS | 31 lipca 2026 | N-PORT |
| RWJ · Invesco Exchange-Traded Fund Trust … | 0,07% | 17 524 SH | 1 października 2026 | Dziennie |
| RSSL · Global X Funds | 0,05% | 9 839 NS | 31 lipca 2026 | N-PORT |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,05% | 118 216 SH | 19 sierpnia 2026 | Dziennie |
| IWM · iShares Trust | 0,05% | 522 674 SH | 11 września 2026 | Dziennie |
| OMFS · Invesco Exchange-Traded Self-Indexe… | 0,04% | 1 600 SH | 1 października 2026 | Dziennie |
| DFAS · Dimensional ETF Trust | 0,04% | 78 417 NS | 31 lipca 2026 | N-PORT |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,04% | 13 769 SH | 1 października 2026 | Dziennie |
| DXUV · Dimensional ETF Trust | 0,02% | 1 726 NS | 31 lipca 2026 | N-PORT |
| DFAT · Dimensional ETF Trust | 0,02% | 39 052 NS | 31 lipca 2026 | N-PORT |
| FHLC · FIDELITY COVINGTON TRUST | 0,02% | 8 812 NS | 31 lipca 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0,02% | 209 049 SH | 19 sierpnia 2026 | Dziennie |
| VHT · VANGUARD WORLD FUND | 0,02% | 54 758 SH | 19 sierpnia 2026 | Dziennie |
| TILT · FlexShares Trust | 0,01% | 3 792 NS | 31 lipca 2026 | N-PORT |
| DFAC · Dimensional ETF Trust | 0,01% | 59 018 NS | 31 lipca 2026 | N-PORT |
| WSML · iShares Trust | 0,01% | 869 SH | 11 września 2026 | Dziennie |
| DFUV · Dimensional ETF Trust | 0,01% | 15 855 NS | 31 lipca 2026 | N-PORT |
| DCOR · Dimensional ETF Trust | 0,01% | 2 879 NS | 31 lipca 2026 | N-PORT |
| DFAU · Dimensional ETF Trust | 0,00% | 6 207 NS | 31 lipca 2026 | N-PORT |
| DFUS · Dimensional ETF Trust | 0,00% | 6 331 NS | 31 lipca 2026 | N-PORT |
| IWV · iShares Trust | 0,00% | 5 496 SH | 11 września 2026 | Dziennie |
| ITOT · iShares Trust | 0,00% | 23 783 SH | 11 września 2026 | Dziennie |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 609 433 SH | 19 sierpnia 2026 | Dziennie |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 1 721 SH | 19 sierpnia 2026 | Dziennie |
| IJR · iShares Trust | · | 1 112 228 SH | 10 września 2026 | Dziennie |
| IJT · iShares Trust | · | 172 474 SH | 9 września 2026 | Dziennie |
| XJR · iShares Trust | · | 2 527 SH | 31 sierpnia 2026 | Dziennie |
| ISCB · iShares Trust | · | 984 SH | 11 września 2026 | Dziennie |
| ISCV · iShares Trust | · | 4 722 SH | 11 września 2026 | Dziennie |
| SMMV · iShares Trust | · | 6 541 SH | 19 sierpnia 2026 | Dziennie |
ANIP Konsensus analityków Bycze i niedźwiedzie opinie analityków, 12-miesięczny cel cenowy, potencjał wzrostu
ocena · 14 analityków
KUP
Średni cel
$104.00
+44,1%
5 35,7%
Mocne kupno
7 50,0%
Kup
2 14,3%
Trzymaj
0 0,0%
Sprzedaj
0 0,0%
Mocna sprzedaż
12-miesięczny cel cenowy
9 analityków · 2026-10-03Średnia cel $105.78 +46,5%
← Poniżej wszystkich celów
Aktualna cena $72.18
Niski$85.00
Średnia$105.78
Wysoki$121.00
Porównanie z porównywalnymi firmami (podbranża GICS) Kluczowe metryki w porównaniu do konkurentów z sektora
Podstawa R/R, ceny według zamknięcia z ostatniego końca roku obrotowego każdej spółki.
| Ticker | Kapitalizacja Rynkowa | P/E | Przychody r/r | Marża Netto | ROE | Marża brutto |
|---|---|---|---|---|---|---|
| ANIP | $1.78B | 23.8 | 43.8% | 8.9% | 16.6% | · |
| GPCR | $14.78B | -86.9 | · | · | -12.3% | · |
| TRVI | $1.61B | -39.1 | · | · | -22.4% | · |
| NUVB | $3.03B | -14.9 | 699.0% | -325.3% | -60.3% | · |
| SEPN | $1.25B | -25.3 | 4174.5% | -106.4% | -12.9% | · |
| OCUL | $2.62B | -8.5 | -18.5% | -511.9% | -55.4% | · |
| NKTR | $862M | -4.3 | -43.9% | -297.1% | -500.1% | · |
| RAPP | $1.45B | -10.6 | · | · | -29.8% | · |
| ETON | $457M | · | 104.9% | -5.8% | -18.4% | 53.5% |
| MAZE | $2.04B | -13.6 | · | · | -598.9% | · |
| INVA | · | 6.1 | 14.7% | · | · | · |
Najnowsze wiadomości Najnowsze nagłówki wspominające o tej firmie
Moje wskaźniki Twoja osobista lista obserwowanych — wybrane wiersze z Pełnych Fundamentów
Wybierz wskaźniki, które są dla Ciebie ważne — kliknij + obok dowolnego wiersza w sekcji Pełne dane fundamentalne powyżej.
Twój wybór został zapisany i będzie Ci towarzyszył we wszystkich tickerach.
Źródło: SEC 10-Q złożone Sie 7, 2026